Acambis has completed its BLA to the FDA for its experimental smallpox vaccine, ACAM2000. The drug was given fast-track status in late 2004. Report [1]
Links:
[1] http://www.pharmaceutical-business-review.com/article_news.asp?guid=4786CC23-02DD-4DCD-853E-3CEC6B515D21